Daiwa Securities Group Inc. Sells 3,025 Shares of Molina Healthcare, Inc. (NYSE:MOH)

Daiwa Securities Group Inc. cut its stake in shares of Molina Healthcare, Inc. (NYSE:MOH) by 10.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 24,775 shares of the company’s stock after selling 3,025 shares during the quarter. Daiwa Securities Group Inc.’s holdings in Molina Healthcare were worth $8,951,000 at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. Annis Gardner Whiting Capital Advisors LLC purchased a new position in shares of Molina Healthcare during the third quarter worth approximately $30,000. Coppell Advisory Solutions Corp. purchased a new position in shares of Molina Healthcare during the fourth quarter worth approximately $34,000. VisionPoint Advisory Group LLC increased its position in shares of Molina Healthcare by 105.6% during the third quarter. VisionPoint Advisory Group LLC now owns 111 shares of the company’s stock worth $36,000 after acquiring an additional 57 shares during the period. Friedenthal Financial purchased a new position in shares of Molina Healthcare during the fourth quarter worth approximately $43,000. Finally, Brown Brothers Harriman & Co. purchased a new position in shares of Molina Healthcare during the first quarter worth approximately $40,000. 98.50% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Molina Healthcare

In other news, CFO Mark Lowell Keim sold 15,000 shares of Molina Healthcare stock in a transaction on Monday, February 12th. The shares were sold at an average price of $386.56, for a total transaction of $5,798,400.00. Following the completion of the sale, the chief financial officer now directly owns 36,531 shares in the company, valued at $14,121,423.36. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In other news, Director Richard M. Schapiro sold 711 shares of Molina Healthcare stock in a transaction on Monday, February 12th. The shares were sold at an average price of $384.06, for a total transaction of $273,066.66. Following the completion of the sale, the director now directly owns 12,207 shares in the company, valued at $4,688,220.42. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, CFO Mark Lowell Keim sold 15,000 shares of Molina Healthcare stock in a transaction on Monday, February 12th. The stock was sold at an average price of $386.56, for a total transaction of $5,798,400.00. Following the sale, the chief financial officer now owns 36,531 shares of the company’s stock, valued at $14,121,423.36. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 16,711 shares of company stock worth $6,472,517. Company insiders own 1.10% of the company’s stock.

Molina Healthcare Price Performance

NYSE MOH opened at $360.84 on Friday. The firm’s fifty day simple moving average is $394.75 and its two-hundred day simple moving average is $370.71. The company has a current ratio of 1.54, a quick ratio of 1.54 and a debt-to-equity ratio of 0.57. Molina Healthcare, Inc. has a 12-month low of $266.35 and a 12-month high of $423.92. The firm has a market capitalization of $21.14 billion, a P/E ratio of 19.21, a P/E/G ratio of 1.01 and a beta of 0.47.

Molina Healthcare (NYSE:MOH) last released its quarterly earnings results on Wednesday, February 7th. The company reported $4.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.31 by $0.07. Molina Healthcare had a net margin of 3.20% and a return on equity of 32.34%. The business had revenue of $9.05 billion for the quarter, compared to analyst estimates of $8.35 billion. During the same period in the previous year, the company earned $4.10 earnings per share. The business’s revenue for the quarter was up 10.0% on a year-over-year basis. Analysts forecast that Molina Healthcare, Inc. will post 23.62 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

MOH has been the topic of a number of research reports. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $406.00 target price on shares of Molina Healthcare in a research report on Thursday, April 4th. Bank of America lowered shares of Molina Healthcare from a “neutral” rating to an “underperform” rating and set a $439.00 price objective on the stock. in a report on Thursday, March 28th. Wells Fargo & Company cut their price objective on shares of Molina Healthcare from $440.00 to $410.00 and set an “equal weight” rating on the stock in a report on Monday. Barclays began coverage on shares of Molina Healthcare in a report on Wednesday, March 6th. They set an “equal weight” rating and a $437.00 price objective on the stock. Finally, Truist Financial lifted their price objective on shares of Molina Healthcare from $435.00 to $460.00 and gave the company a “buy” rating in a report on Tuesday, February 20th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat, Molina Healthcare presently has an average rating of “Hold” and a consensus price target of $393.09.

About Molina Healthcare

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.